Week 3 Flashcards

1
Q

PPE is initially recognised at cost. To recognise a cost outlay as an asset, the following criteria must be satisfied:

A

– it is probable that economic benefits will flow to the entity (not necessarily generated by the asset)

– the cost can be reliably measured.

Paragraph 7 of AASB 116/IAS 16

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Where no new future economic benefits are expected to flow to the entity

A

costs incurred should be expensed (e.g. repairs but not betterments)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Component parts (with different useful lives) are

A

required to be identified and accounted for separately.

Example: not enough to recognise aircraft as a single asset- the engine, frame and fittings of an aircraft are likely to have different useful lives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial measurement of cost

PPE is initially measured at the cost of the asset which includes

A

Purchase price (at fair value) (includes duties and taxes after deducting rebates and discounts)

Directly attributable costs (required to bring the asset to the location and condition necessary for it to operate)

Initial estimate of costs of dismantling, removing the item or restoring the site (at present value)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PPE to be measured at either

A

cost or fair value

the policy chosen must apply to the whole class of assets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Entities may switch from fair value to cost… i.e. revaluation model to cost model

A

Entities may switch from fair value to cost for justifiable reasons (will make the financial statements more useful to users; in particular, will the information be more relevant and/or more reliable — a requirement under AASB 108/IAS 8 paragraph 14.

and with adequate disclosures and need to adjust the information prepared previously if the switch is to cost.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cost model

A

AASB 116 requires that assets are carried at cost less any accumulated:

– Depreciation
– Impairment losses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Revaluation model is to be used

A

AASB 116 allows the revaluation model to be used for classes of assets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Features of revaluation model

A
  • Any revaluation of PPE must be to fair value.
  • Market price is to be used where an active and liquid

market exists.

  • Frequency of revaluations is not specified, but must be

performed with sufficient regularity such that the carrying

amount of assets is not materially different from their FV.

  • Revaluation is performed on a class basis (requires class of assets to be revalued), but accounting

for revaluation is performed on an asset-by-asset basis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Revaluation model

If FV(fair value)>CA:

A

there is an increase in the fair value of the asset

revaluation increment (potential profit – recognised as other comprehensive income (OCI), not profit and loss and is accumulated in equity as asset revaluation surplus (ASR)).

which is reported under reserves section under statement of financial position

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Revaluation model

If FV(fair value)<ca:>
</ca:>
A

revaluation decrement (potential loss – recognised as part of profit and loss).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

To account for revaluation increments/decrements for depreciable assets, we can use the net method or gross method

net method

A

Net method - General procedure:
• Any balance of accumulated depreciation is credited to the asset account prior to revaluation, so the amount recognised for the asset is the revalued amount.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

To account for revaluation increments/decrements for depreciable assets, we can use the net method
or the gross method.

Gross method

A

Accumulated depreciation may be restated proportionately with the change in gross carrying amount of the asset, so the carrying amount after revaluation is the revalued amount.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

revaluation model an asset is

A

initially recorded at cost but subsequently its carrying amount is increased to account for any appreciation in value.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The difference between cost model and revaluation model

A

revaluation model allows both downward and upward adjustment in value of an asset while cost model allows only downward adjustment due to impairment loss

revaluation model: impairment loss is recognised as revalaution decrement cost model: impairment loss is recognised directly in P&L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Transfers may be made from the asset revaluation surplus (ARS) in the following circumstances:

A

– When a revalued asset is derecognised (i.e. scrapped or sold): the balance in the ARS may be transferred to retained earnings.

– When a revalued asset is being depreciated: the ARS may be progressively transferred to retained earnings over the useful life of the asset.

– Bonus shares may be issued from the ARS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Impairment loss has occurred when

A

an asset’s carrying amount (CA) is more than its recoverable amount (RA).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Entities are required to conduct impairment tests to

A

ensure their assets are not overstated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Not all assets require impairment test. Notable exclusions:

A

– Inventories

– Deferred tax assets
– Assets held for resale.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

The following assets must be tested annually:

A

– Intangibles with indefinite useful lives
– Intangibles not yet available for use
– Goodwill acquired in a business combination.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

External indicators of impairment include

A

– Decline in market value – technological advancements

– Adverse changes in entity’s environment/market – eg a competitor may have patented a new product, significant drop in commodity prices, for example, would have an adverse impact on the estimation of future cash flows when determining an asset’s value in use.

– Increases in interest rates – increases the discount rate which affects assessment of an entity’s present value of future cash flows.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Internal indicators include:

A

– Obsolescence or physical damage

– Change in asset use – has the asset become idle?

– An asset’s economic performance being worse than expected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

If carrying amount (CA) > recoverable amount (RA) –

A

an imapirmentl loss has occured and the asset needs to be written down to its RA (AASB 136).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

If carrying amount (CA) > recoverable amount (RA) – asset needs to be written down to its RA (AASB 136).

Carrying amount

A

cost of asset (or revalued amount) less acc. depreciation and impairment losses thereon.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

If carrying amount (CA) > recoverable amount (RA) – asset needs to be written down to its RA (AASB 136).

Recoverable amount

A

higher of:
• Fair value, less costs to sell (or net selling price): amount obtained from the sale of an asset less the costs of disposal.
• Value in use: present value of the future cash flowsexpected to be derived from an asset.

26
Q

Fair value is determined using the following ‘value hierarchy’:

A
  • Price in a binding sale agreement
  • Market price (current bid price)
  • Appropriate estimation (e.g. using NPV calculations).
27
Q

Costs of disposal include

A
  • legal fees
  • stamp duty
  • costs of removing the asset etc.
28
Q

what is an impairment loss

A

he amount by which the carrying amount of an asset or CGU exceeds its recoverable amount.

29
Q

Intangible assets acquired externally (either separately or as part of a business combination) can be recognised if

A

the general recognition criteria for assets are satisfied.

30
Q

The expenditure incurred internally to generate future economic benefits does not

A

The expenditure incurred internally to generate future economic benefits does not normally result in the recognition of an intangible asset – instead, a so called internally generated goodwill may be created, but that cannot be recognised as an asset.

31
Q

Also, AASB 138 specifically states that

A

internally generated brands, mastheads, publishing titles, customer lists and items similar in substance shall not be recognised as intangible assets.

– The expenditure on those cannot be distinguished from the cost of developing the business as a whole.

32
Q

recognition of intangible assets

With regards to R&D activities,

A

With regards to R&D activities, the research expenditure is to be written off as expense as incurred:

– No intangible asset arising from research (or from the research phase of an internal R&D project) shall be recognised.

33
Q

the development expenditure can be capitalised and recognised as

i.e. intangible asset can only be recognised from development outlays if

A

“Deferred development costs”

all the criteria from para 57 AASB 138 are met

– technical feasibility of completing

– intention to complete and use or sell

– ability to use or sell

– availability of resources

– existence of a market or internal usefulness.

– ability to measure costs reliably.

34
Q

what Costs are included as part of deferred development costs:

A

all directly attributable costs necessary to create, produce and prepare the asset to be capable of operating in the manner intended by management (AASB 138, par. 66).

35
Q

Examples of directly attributable costs are:

A

costs of materials and services used;

costs of employee benefits arising from generation of the intangible asset;

fees to register a legal right;

amortisation of patents and rights used.

36
Q

Additional key issues on regarding R&D expenditure:

Where the total of the deferred development costs exceeds the expected recoverable amount (RA),

A

the deferred development costs must be written down to the RA.

37
Q

Additional key issues on regarding R&D expenditure:

Expenditure written off in one period

A

cannot be subsequently written back onto the balance sheet.

38
Q

Initial measurement of Intangible assets acquired from an external party separately?

A

intangible assets obtained by separate acquisition are initially measured at cost:

– Cost can usually be measured reliably, although there may be issues where the acquirer is giving up non-monetary assets rather than cash.

39
Q

Intangible assets acquired as part of a business combination are

A

are initially measured at fair value in accordance with AASB 3 Business Combinations.

– Fair value measures used may include:
• quotedmarketpricesinanactivemarket
• recent transactions in the same or similar items

40
Q

initial measurement of Intangible assets internally generated

A

Intangible assets internally generated (i.e. deferred development costs) are initially measured at cost.

41
Q

intangible asset with finite useful life

A

Amortized on a systematic basis over its useful life

42
Q

intangible asset with infinite useful life

A

Tested for impairment by comparing its recoverable amount with its carrying amount annually and whenever there is an indication that the intangible asset may be impaired.

43
Q

The residual value of intangible assets with finite lives is

A

generally considered to be zero, unless:

– there is a commitment by a third party to purchase the asset at the end of its useful life, or

– there is an active market for the asset, and the residual amount can be determined by reference to that market and it is probable that the market will still exist at the end of the useful life of the asset.

44
Q

Active market is defined as

A

(AASB 13):

– A market in which transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis

45
Q

Amortisation method should

A

reflect the pattern in which the economic benefits are derived - if the pattern cannot be determined reliably, the straight-line amortisation method is to be used.

46
Q

Amortisation charges to be expensed unless

A

another standard requires the amount to be included in the carrying amount of another asset.

47
Q

can intangible assets be revalued?

A

Only the externally acquired intangible assets are permitted to be revalued, but only if there is an “active market” for them.

  • It is ‘uncommon’ for active markets to exist for most intangible assets because of their unique nature.

Where revaluation occurs it must be to fair value.

Revaluations should be done regularly.

Any subsequent amortisation charges to be based on revalued amount taking into account remaining useful life.

48
Q

AASB138 places a number of severe restrictions on

A

the recognition of internally generated intangible assets and on revaluation of those assets.

49
Q

AASB138 places a number of severe restrictions on the recognition of internally generated intangible assets and on revaluation of those assets.

Requirement that all research expenditure be written off as incurred is very conservative?

A

Discourage entities from undertaking certain research as it will impact negatively on profits

50
Q

• Only allowed to revalue identifiable intangible assets if there is an ‘active’ market for them; however

A

ctive markets do not exist for the vast majority of intangible assets.

– In most cases where intangible assets are recognised they will be recorded at cost, less accumulated amortisation, rather than being shown at their fair value, with ‘fair value’ potentially being more relevant to users of financial statements.

51
Q

How may expected economic benefits arise?

A

because of use of that asset in conjunction with other assets

Paragraph 11 of AASB 116/IAS 16 notes that certain assets may not of themselves generate future benefits, but instead the assets may be necessary for the entity as a whole to generate future benefits

52
Q

measured reliably’ refers to recognition of PPE only where the measurement purports to

A

faithfully represent the economic substance of the item and is free from material error or bias. As a result of reliable measurement, users can depend on this information to make economic decisions

53
Q

to determine which costs can be capitalised into the cost of the asset,

A

the following question is asked.

Are the costs directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management?

According to paragraph 16 of AASB 116/IAS 16, if the answer is ‘yes’, then the costs are capitalised into the cost of the asset; if the answer is ‘no’, then the costs are expensed and recognised in profit or loss.

54
Q

At the point of initial recognition of an item of PPE, the asset is measured at cost, which is the purchase price plus directly attributable costs and dismantling, removal, and/or restoration costs. After this initial recognition, an entity has a choice regarding the measurement basis to be adopted. Paragraph 29 of AASB 116/IAS 16 details two possible measurement models:

A

the cost model

the revaluation model.

55
Q

under the revaluation model

A

assets are measured at fair value

56
Q

purpose of the impairment test is

A

to determine whether the carrying amount of an asset exceeds its recoverable amount.

The evidence of impairment relates to variables that may support the belief that the book value of the asset under investigation overstates the future cash flows expected to be generated from its use or sale.

57
Q

Under the cost model

A

impairment loss is recognised directly in profit and loss

58
Q

There are other intangible assets that can never be recognised, regardless of whether they meet the recognition tests.

A

Research costs.

Specific internally generated intangible assets.

59
Q

There are other intangible assets that can never be recognised, regardless of whether they meet the recognition tests.

research costs

A

These costs must always be expensed. This non-recognition applies only to internally generated research and not to in-process research acquired from other entities

60
Q

There are other intangible assets that can never be recognised, regardless of whether they meet the recognition tests.

some internally generated intangible assets

A

The reason for non-recognition relates to the perceived inability to be able to measure the cost of these assets as they are internally generated. The cost of developing these assets is seen to be indistinguishable from the cost of developing the business as a whole

61
Q

If all these recognition criteria are met for development outlay to be recognised as an intangible asset as per para 57 AASB 138

A

the asset is measured at cost, being the sum of expenditure incurred from the point of time the recognition criteria are met. Any expenditure on development while the recognition criteria are not met must be expensed.

62
Q

the criteria from paragraph 57 of AASB 138/IAS 38 are met:

A

the technical feasibility of completing the intangible asset so that it will be available for use or sale;

its intention to complete the intangible asset and use or sell it;

its ability to use or sell the intangible asset;

how the intangible asset will generate probable future economic benefits. Among other things, the entity can demonstrate the existence of a market for the output of the intangible asset or the intangible asset itself or, if it is to be used internally, the usefulness of the intangible asset;

the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and

its ability to measure reliably the expenditure attributable to the intangible asset during its development.

(Loftus 159)

Loftus, Janice, Ken Leo, Noel Boys, Belinda Luke, Sorin Daniliuc, Hong Ang, Karyn Byrnes. Financial Reporting. John Wiley & Sons Australia,, 05/2015. VitalBook file.